Salmeterol attenuates the inflammatory response in asthma and decreases the pro-inflammatory cytokine secretion of dendritic cells

Cellular and Molecular Immunology

Volumn 9, Issue 3, 2012, Pages 267-275

  Hu, Zhenli ^a   Chen, Ruohua ^a   Cai, Zhijian ^b   Yu, Lei ^b   Fei, Yang ^b   Weng, Lixia ^b   Wang, Jinghan ^c   Ge, Xiahui ^a   Zhu, Tianyi ^a   Wang, Jianli ^b   Bai, Chong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

asthma; dendritic cells; pro inflammatory cytokines; salmeterol

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; METHACHOLINE; MITOGEN ACTIVATED PROTEIN KINASE; OVALBUMIN; SALMETEROL; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASTHMA; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; GENE EXPRESSION; IMMUNOMODULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; WESTERN BLOTTING;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ALBUTEROL; ANIMALS; ASTHMA; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNIZATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; NF-KAPPA B; OVALBUMIN;

MURINAE; MUS;

EID: 84860858017     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2011.56     Document Type: Article

References (37)

1. Kuipers H, Lambrecht BN. The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma. Curr Opin Immunol 2004; 16: 702-708. (Pubitemid 39423657)
2. Nguyen LP, Lin R, Parra S, Omoluabi O, Hanania NA, Tuvim MJ et al. Beta2- adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci USA 2009; 106: 2435-2440.
3. Johnson M. Pharmacology of long-acting beta-agonists. Ann Allergy Asthma Immunol 1995; 75: 177-179.
4. Johnson M. Effects of beta2-agonists on resident and infiltrating inflammatory cells. J Allergy Clin Immunol 2002; 110(6 Suppl): S282-S290. (Pubitemid 35471717)
5. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252. (Pubitemid 28155090)
6. Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 2000; 106: 551-559. (Pubitemid 30666388)
7. Lambrecht BN, Pauwels RA, Fazekas de St Groth B. Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model. J Immunol 2000; 164: 2937-2946. (Pubitemid 30148951)
8. KuipersH, Heirman C, Hijdra D, Muskens F, Willart M, van MeirvenneS et al.Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization. J Leukoc Biol 2004; 76: 1028-1038. (Pubitemid 39458714)
9. Schipf A, Heilmann A, Boue L, Mossmann H, Brocker T, Röcken M. Th2 cells shape the differentiation of developing T cell responses during interactions with dendritic cells in vivo. Eur J Immunol 2003; 33: 1697-1706. (Pubitemid 36790431)
10. Barkhordari E, Rezaei N, Ansaripour B, Larki P, Alighardashi M, Ahmadi-Ashtiani HR et al. Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome. J Clin Immunol 2010; 30: 74-79.
11. Subratty AH, Hooloman NK. Role of circulating inflammatory cytokines in patients during an acute attack of bronchial asthma. Indian J Chest Dis Allied Sci 1998; 40: 17-21.
12. Seiffert K, Hosoi J, Torii H, Ozawa H, Ding W, Campton K et al. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J Immunol 2002; 168: 6128-6135. (Pubitemid 34620030)
13. Machida I, Matsuse Y, Kondo T, Kawano S, Saeki S, Tomari Y et al. Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma. J Immunol 2004; 172: 1833-1838. (Pubitemid 38116832)
14. Zhang M, Tang H, Guo Z, An H, Zhu X, Song W et al. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat Immunol 2004; 5: 1124-1133. (Pubitemid 39549626)
15. Wang D, Guo MX, Hu HM, Zhao ZZ, Qiu HL, Shao HJ et al. Human T-cell leukemia virus type 1 oncoprotein tax represses ZNF268 expression through the cAMP-responsive element-binding protein/activating transcription factor pathway. J Biol Chem 2008; 283: 16299-16308.
16. Wang D, Lou J, Ouyang C, Chen W, Liu Y, Liu X et al. Ras-related protein Rab10 facilitates TLR4 signaling by promoting replenishment of TLR4 onto the plasma membrane. Proc Natl Acad Sci USA 2010; 107: 13806-13811.
17. Xanthou G, Alissafi T, Semitekolou M, Simoes DC, Economidou E, Gaga M et al. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med 2007; 13: 570-578. (Pubitemid 46828486)
18. Semitekolou M, Alissafi T, Aggelakopoulou M, Kourepini E, Kariyawasam HH, Kay AB et al. Activin-A that induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease. J Exp Med 2009; 206: 1769-1785.
19. Bates JH, Irvin CG. Measuring lung function in mice: the phenotyping uncertainty principle. J Appl Physiol 2003; 94: 1297-1306. (Pubitemid 36348804)
20. Shen HH, Ochkur SI, McGarry MP, Crosby JR, Hines EM, Borchers MT et al. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J Immunol 2003; 170: 3296-3305. (Pubitemid 36302208)
21. Capka V, Carter SJ. Minimizing matrix effects in the development of a method for the determination of salmeterol in human plasma by LC/MS/MS at low pg/mL concentration levels. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 856: 285-293. (Pubitemid 47302926)
22. Callaerts-Vegh Z, Evans KL, Dudekula N, Cuba D, Knoll BJ, Callaerts PF et al. Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci USA 2004; 101: 4948-4953. (Pubitemid 38469183)
23. Cates CJ, Lasserson TJ. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2010; (1): CD007694.
24. Storms W, Chervinsky P, Ghannam AF, Bird S, Hustad CM, Edelman JM et al. A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge. Respir Med 2004; 98: 1051-1062. (Pubitemid 39317934)
25. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008; 133: 235-249. (Pubitemid 351512299)
26. Lutz MB, Kukutsch NA, Menges M, Rossner S, Schuler G. Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur J Immunol 2000; 30: 1048-1052. (Pubitemid 30216220)
27. Saitoh S. Chaperones and transport proteins regulate TLR4 trafficking and activation. Immunobiology 2009; 214: 594-600.
28. Masoli M, Weatherall M, Ayling J, Williams M, Beasley R. The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhaler. Respir Med 2005; 99: 545-552. (Pubitemid 40468500)
29. Machida I, Matsuse H, Kondo Y, Kawano T, Saeki S, Tomari T et al. Effects of various anti-asthmatic agents on mite allergen-pulsed murine bone marrow-derived dendritic cells. Clin Exp Allergy 2005; 35: 884-888. (Pubitemid 41032536)
30. Berry M, Brightling C, Pavord I, Wardlaw A. TNF-alpha in asthma. Curr Opin Pharmacol 2007; 7: 279-282.
31. Doganci A, Saver K, Karwot R, Finotto S. Pathological role of IL-6 in the experimental allergic bronchial asthma in mice. Clin Rev Allergy Immunol 2005; 28: 257-270.
32. Johnson VJ, Yucesoy B, Luster MI. Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanateinduced asthma. J Allergy Clin Immunol 2005; 116: 851-858. (Pubitemid 41400551)
33. Lakhani SA, Bogue CW. Toll-like receptor signaling in sepsis. Curr Opin Pediatr 2003; 15: 278-282. (Pubitemid 36578077)
34. Zaru R, Ronkina N, Gaestel M, Arthur JS, Watts C. The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nat Immunol 2007; 8: 1227-1235. (Pubitemid 350011762)
35. Pomerantz JL, Baltimore D. Two pathways to NF-kappaB. Mol Cell 2002; 10: 693-695.
36. Fang Y, Lahiri J, Picard L. G protein-coupled receptor microarrays for drug discovery. Drug Discov Today 2003; 8: 755-761. (Pubitemid 37011247)
37. Kolch W. Ras/Raf signalling and emerging pharmacotherapeutic targets. Expert Opin Pharmacother 2002; 3: 709-718. (Pubitemid 34649700)